Success Story: Turning Cell Signaling Into New Neurological Therapies: NIW Approved for a Taiwanese PhD Student Advancing GPCR and Ion Channel Drug Discovery

Posted by wegreened on May 1, 2026 in NIW, Medical (Gastroenterology, Cancer, Cancer Pharmacology, Cardiology, Immunology, Pathology, Hematology, Neurology, Neuroscience, Urology, Gynecology, Dentistry, Endocrinology)

On February 13^th, 2026, we received another EB-2 NIW (National Interest Waiver) approval for a PhD student in the field of Neuroscience (Approval Notice).

General Field: Neuroscience

Position at the Time of Case Filing: PhD student

Country of Origin: Taiwan

State of Residence at the Time of Filing: Florida

Approval Notice Date: February 13^th, 2026

Processing Time: 1 year, 6 months, 21 days (Premium Processing Requested)

Case Summary:

This NIW approval features a Taiwanese PhD student whose work addresses a core bottleneck in neurological therapy development, identifying clear molecular mechanisms that can translate into testable drug targets. The proposed endeavor focuses on using molecular and biochemical approaches to clarify how G protein-coupled receptors (GPCRs) and ion channels shape cellular signaling, supporting drug discovery directions for conditions such as chronic pain, addiction, depression, and seizures. At the time of filing, the client was continuing this research in the United States through an appointment aligned with the proposed endeavor.

Research with National Importance

The NIW filing established substantial merit and national importance by linking improved target discovery to U.S. public health priorities, particularly the need for more effective approaches to chronic pain and addiction. By strengthening the mechanistic understanding of GPCR and ion-channel signaling, the work expands the pool of actionable targets and supports more precise, safety-minded therapeutic development.

Academic Contributions and Recognition

The petition documented 3 peer-reviewed journal articles and 4 first-authored abstracts, with the work receiving 107 citations. To show influence beyond raw totals, the filing emphasized normalized impact indicators demonstrating strong citation-percentile performance for multiple publications, supporting the conclusion that other researchers are actively using and building upon the client’s findings.

NIW Approval and Outlook

The I-140 NIW petition was filed on July 23rd, 2024, and approved on February 13th, 2026, following an upgrade to premium processing. The approval reflects a successful NIW showing that the endeavor carries substantial merit and national importance, that the client is well-positioned to advance it through a documented record of publications and citations, and that granting the waiver supports continued progress in biomedical innovation with clear relevance to U.S. health needs.`

--------------------------------------------

North America Immigration Law Group (Chen Immigration Law Associates) is a U.S. immigration law firm dedicated to representing corporations, research institutions, and individuals from all 50 U.S. states regarding I-140 immigration petitions. We specialize in employment-based immigration petition and have a proven record of high success rate for the categories of: EB2-NIW (National Interest Waiver), EB1-A (Alien of Extraordinary Ability), EB1-B (Outstanding Researcher/Professor) and O-1 (Alien of Extraordinary Ability).

Our Sixty-four Thousand I-140 Approvals Provide Unprecedented Insight into the USCIS Adjudication Trend

With nearly 64,000 EB-1A, EB-1B, EB-2 NIW and O-1 cases approved, we have first hand information on the manner in which the USCIS adjudicate I-140 cases. As the USCIS has constantly changed its adjudication standards for the EB-1A, EB-1B and EB-2 NIW categories, our firm's huge database of successful cases gives you unprecedented insight to USCIS adjudication trends. We carefully analyze the data for all of our cases and apply the results of our analyses toward giving our clients up-to-date advice and adapting our strategies such that we remain on par with the ever-shifting landscape of immigration law in the U.S. With us, you will always have access to important updates, strategies, and information so that you can make the most informed decisions about your case.

We Have Helped Tens of Thousands of Clients with Credentials and Backgrounds Similar to Yours

With our exceedingly large number of successful petitions, no matter what credentials you have, no matter your background and field of expertise, no matter your visa status or nationality, chances are we have helped hundreds or even thousands of clients just like you. Our clients are usually impressed with how well we understand their research and work. Our insight and understanding stems from the fact that we have handled many cases with elements similar to yours already, and this helps us devise the best strategies for each individual petition.

Vast Majority of Clients Came to Us Because of Referrals

For years, our firm has attracted new clients based solely on word of mouth, recommendations, and the positive collaboration experiences shared with them by their friends and family. We take pride in our reputation and work hard to ensure that we provide a green card application experience that our clients are happy to share with their friends and colleagues. That is how our cumulative total of approved cases grew from 600 in 2013 to nearly 64,000 in 2025.

Track Record of Success EB-1 and NIW Approvals

(2012.01 - 2025.12)

Category	Approval or Refund^®		Approval or Refiling^TM
	Approval or Refund^®
Category	Approved Sum	Success Rate	Approved Sum	Success Rate
NIW	42,047	99%	5,258	97%
EB1A	9,218	91%	4,534	86%
EB1B	1,488	98%	448	93%
Total	52,753	98%	10,240	92%